Use of sensitivity analysis on a physiologically based pharmacokinetic (PBPK) model for chloroform in rats to determine age-related toxicity.

被引：0
|
作者：
Eklund, CR
Simmons, JE
Evans, MV
机构：
[1] US EPA, PKB, ETD, NHEERL,ORD, Res Triangle Pk, NC 27711 USA
[2] US EPA, HEASD, NERL, ORD, Res Triangle Pk, NC 27711 USA
来源：
TOXICOLOGICAL SCIENCES | 2003年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
883
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [41] Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach
    Chiu, Weihsueh A.
    Okino, Miles S.
    Evans, Marina V.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 241 (01) : 36 - 60
  • [42] Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model
    Yang, Feng
    Tong, Xianping
    McCarver, D. Gail
    Hines, Ronald N.
    Beard, Daniel A.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2006, 33 (04) : 485 - 518
  • [43] Use of Markov chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age
    Allen, Bruce C.
    Hack, C. Eric
    Clewell, Harvey J.
    RISK ANALYSIS, 2007, 27 (04) : 947 - 959
  • [44] A physiologically based pharmacokinetic/pharmacodynamic model for carbofuran in Sprague-Dawley rats using the exposure-related dose estimating model
    Zhang, Xiaofei
    Tsang, Andy M.
    Okino, Miles S.
    Power, Frederick W.
    Knaak, James B.
    Harrison, Lynda S.
    Dary, Curtis C.
    TOXICOLOGICAL SCIENCES, 2007, 100 (02) : 345 - 359
  • [45] Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model
    Timchalk, C
    Kousba, A
    Poet, TS
    TOXICOLOGY LETTERS, 2002, 135 (1-2) : 51 - 59
  • [46] Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification
    Chou, Wei-Chun
    Lin, Zhoumeng
    ENVIRONMENT INTERNATIONAL, 2019, 129 : 408 - 422
  • [47] Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analysess
    Zhang, Zufei
    Imperial, Marjorie Z.
    Patilea-Vrana, Gabriela I.
    Wedagedera, Janak
    Lu Gaohua
    Unadkat, Jashvant D.
    DRUG METABOLISM AND DISPOSITION, 2017, 45 (08) : 920 - 938
  • [48] Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats
    Wei-Chun Chou
    Yi-Hsien Cheng
    Jim E. Riviere
    Nancy A. Monteiro-Riviere
    Wolfgang G. Kreyling
    Zhoumeng Lin
    Particle and Fibre Toxicology, 19
  • [49] Development of an inhalation physiologically based pharmacokinetic (PBPK) model for 2,2, 4-trimethylpentane (TMP) in male Long-Evans rats using gas uptake experiments
    El-Masri, Hisham A.
    Dowd, Sean
    Pegram, Rex A.
    Harrison, Randy
    Yavanhxay, Sisouphanh J.
    Simmons, Jane Ellen
    Evans, Marina
    INHALATION TOXICOLOGY, 2009, 21 (14) : 1176 - 1185
  • [50] Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats
    Chou, Wei-Chun
    Cheng, Yi-Hsien
    Riviere, Jim E.
    Monteiro-Riviere, Nancy A.
    Kreyling, Wolfgang G.
    Lin, Zhoumeng
    PARTICLE AND FIBRE TOXICOLOGY, 2022, 19 (01)
12345